Julian Harrison
Stock Analyst at BTIG
(4.52)
# 285
Out of 5,120 analysts
86
Total ratings
58.23%
Success rate
21.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Julian Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Buy | $118 | $38.12 | +209.55% | 3 | Jan 29, 2026 | |
| ARDX Ardelyx | Reiterates: Buy | $17 | $7.79 | +118.23% | 2 | Jan 29, 2026 | |
| MAZE Maze Therapeutics | Maintains: Buy | $37 → $46 | $46.53 | -1.14% | 4 | Jan 16, 2026 | |
| MREO Mereo BioPharma Group | Reiterates: Buy | $1 | $0.43 | +131.21% | 3 | Jan 16, 2026 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $70 | $32.75 | +113.74% | 4 | Jan 16, 2026 | |
| LQDA Liquidia | Reiterates: Buy | $49 | $44.21 | +10.83% | 6 | Jan 13, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Buy | $63 → $73 | $34.30 | +112.83% | 4 | Jan 12, 2026 | |
| MLTX MoonLake Immunotherapeutics | Upgrades: Buy | $24 | $15.79 | +51.99% | 3 | Jan 9, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $120 → $150 | $111.46 | +34.58% | 4 | Jan 8, 2026 | |
| RZLT Rezolute | Reiterates: Buy | $5 | $3.24 | +54.32% | 5 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $128 → $137 | $65.63 | +108.75% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.38 | +262.32% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $40 | $19.83 | +101.71% | 3 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $38 | $12.71 | +198.98% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $44 | $6.79 | +548.01% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.49 | +301.61% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $61 | $33.20 | +83.73% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $82 | $83.05 | -1.26% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.73 | +69.13% | 3 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $15 | $3.99 | +275.94% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $16.65 | +68.17% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.65 | +155.59% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.40 | - | 3 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $50.54 | - | 2 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $9 | $0.44 | +1,945.45% | 5 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $3.61 | +121.61% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.57 | +1,300.56% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $150 | $0.60 | +24,879.18% | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $475.00 | - | 2 | Feb 11, 2022 |
Nektar Therapeutics
Jan 29, 2026
Reiterates: Buy
Price Target: $118
Current: $38.12
Upside: +209.55%
Ardelyx
Jan 29, 2026
Reiterates: Buy
Price Target: $17
Current: $7.79
Upside: +118.23%
Maze Therapeutics
Jan 16, 2026
Maintains: Buy
Price Target: $37 → $46
Current: $46.53
Upside: -1.14%
Mereo BioPharma Group
Jan 16, 2026
Reiterates: Buy
Price Target: $1
Current: $0.43
Upside: +131.21%
Spyre Therapeutics
Jan 16, 2026
Reiterates: Buy
Price Target: $70
Current: $32.75
Upside: +113.74%
Liquidia
Jan 13, 2026
Reiterates: Buy
Price Target: $49
Current: $44.21
Upside: +10.83%
Oruka Therapeutics
Jan 12, 2026
Maintains: Buy
Price Target: $63 → $73
Current: $34.30
Upside: +112.83%
MoonLake Immunotherapeutics
Jan 9, 2026
Upgrades: Buy
Price Target: $24
Current: $15.79
Upside: +51.99%
ABIVAX Société Anonyme
Jan 8, 2026
Maintains: Buy
Price Target: $120 → $150
Current: $111.46
Upside: +34.58%
Rezolute
Jan 8, 2026
Reiterates: Buy
Price Target: $5
Current: $3.24
Upside: +54.32%
Jan 6, 2026
Maintains: Buy
Price Target: $128 → $137
Current: $65.63
Upside: +108.75%
Dec 2, 2025
Reiterates: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Nov 26, 2025
Maintains: Buy
Price Target: $25 → $40
Current: $19.83
Upside: +101.71%
Nov 24, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $12.71
Upside: +198.98%
Nov 14, 2025
Maintains: Buy
Price Target: $42 → $44
Current: $6.79
Upside: +548.01%
Nov 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.49
Upside: +301.61%
Nov 4, 2025
Reiterates: Buy
Price Target: $61
Current: $33.20
Upside: +83.73%
Oct 28, 2025
Reiterates: Buy
Price Target: $82
Current: $83.05
Upside: -1.26%
Oct 16, 2025
Reiterates: Buy
Price Target: $8
Current: $4.73
Upside: +69.13%
Oct 13, 2025
Maintains: Buy
Price Target: $55 → $15
Current: $3.99
Upside: +275.94%
Oct 9, 2025
Initiates: Buy
Price Target: $28
Current: $16.65
Upside: +68.17%
Sep 29, 2025
Reiterates: Buy
Price Target: $40
Current: $15.65
Upside: +155.59%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $18.40
Upside: -
Dec 2, 2024
Downgrades: Neutral
Price Target: n/a
Current: $50.54
Upside: -
Nov 29, 2024
Maintains: Buy
Price Target: $50 → $9
Current: $0.44
Upside: +1,945.45%
Nov 19, 2024
Upgrades: Buy
Price Target: $8
Current: $3.61
Upside: +121.61%
Nov 18, 2024
Initiates: Buy
Price Target: $8
Current: $0.57
Upside: +1,300.56%
Oct 11, 2023
Reinstates: Buy
Price Target: $150
Current: $0.60
Upside: +24,879.18%
Feb 11, 2022
Initiates: Neutral
Price Target: n/a
Current: $475.00
Upside: -